HEADER TRANSFERASE 16-FEB-06 2G2H
TITLE A SRC-LIKE INACTIVE CONFORMATION IN THE ABL TYROSINE KINASE DOMAIN
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: ABL TYROSINE;
COMPND 3 CHAIN: A, B;
COMPND 4 FRAGMENT: ABL TYROSINE KINASE DOMAIN;
COMPND 5 SYNONYM: P150, C- ABL, ABELSON MURINE LEUKEMIA VIRAL ONCOGENE HOMOLOG
COMPND 6 1;
COMPND 7 ENGINEERED: YES;
COMPND 8 MUTATION: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: ABL1, ABL, JTK7;
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562
KEYWDS PROTEIN KINASE, TRANSFERASE
EXPDTA X-RAY DIFFRACTION
AUTHOR N.M.LEVINSON,O.KUCHMENT
REVDAT 4 30-AUG-23 2G2H 1 REMARK
REVDAT 3 20-OCT-21 2G2H 1 REMARK SEQADV
REVDAT 2 24-FEB-09 2G2H 1 VERSN
REVDAT 1 23-MAY-06 2G2H 0
JRNL AUTH N.M.LEVINSON,O.KUCHMENT,K.SHEN,M.A.YOUNG,M.KOLDOBSKIY,
JRNL AUTH 2 M.KARPLUS,P.A.COLE,J.KURIYAN
JRNL TITL A SRC-LIKE INACTIVE CONFORMATION IN THE ABL TYROSINE KINASE
JRNL TITL 2 DOMAIN.
JRNL REF PLOS BIOL. V. 4 753 2006
JRNL REFN ISSN 1544-9173
JRNL PMID 16640460
JRNL DOI 10.1371/JOURNAL.PBIO.0040144
REMARK 2
REMARK 2 RESOLUTION. 2.00 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : CNS 1.1
REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE-
REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU,
REMARK 3 : READ,RICE,SIMONSON,WARREN
REMARK 3
REMARK 3 REFINEMENT TARGET : ENGH & HUBER
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL
REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL
REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL
REMARK 3 NUMBER OF REFLECTIONS : 51722
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : NULL
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING SET) : 0.193
REMARK 3 FREE R VALUE : 0.213
REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL
REMARK 3 FREE R VALUE TEST SET COUNT : 3664
REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : NULL
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL
REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL
REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL
REMARK 3 BIN R VALUE (WORKING SET) : NULL
REMARK 3 BIN FREE R VALUE : NULL
REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL
REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL
REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 4418
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 58
REMARK 3 SOLVENT ATOMS : 413
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : NULL
REMARK 3 B22 (A**2) : NULL
REMARK 3 B33 (A**2) : NULL
REMARK 3 B12 (A**2) : NULL
REMARK 3 B13 (A**2) : NULL
REMARK 3 B23 (A**2) : NULL
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL
REMARK 3 ESD FROM SIGMAA (A) : NULL
REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL
REMARK 3
REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL
REMARK 3 ESD FROM C-V SIGMAA (A) : NULL
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 BOND LENGTHS (A) : 0.006
REMARK 3 BOND ANGLES (DEGREES) : 1.240
REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL
REMARK 3 IMPROPER ANGLES (DEGREES) : NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL MODEL : ISOTROPIC
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA
REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3
REMARK 3 BULK SOLVENT MODELING.
REMARK 3 METHOD USED : NULL
REMARK 3 KSOL : NULL
REMARK 3 BSOL : NULL
REMARK 3
REMARK 3 NCS MODEL : NULL
REMARK 3
REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT
REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL
REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL
REMARK 3
REMARK 3 PARAMETER FILE 1 : NULL
REMARK 3 TOPOLOGY FILE 1 : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 2G2H COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-APR-06.
REMARK 100 THE DEPOSITION ID IS D_1000036605.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : NULL
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : 3.5
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : ALS
REMARK 200 BEAMLINE : 8.2.2
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : NULL
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : NULL
REMARK 200 DETECTOR MANUFACTURER : NULL
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000
REMARK 200 DATA SCALING SOFTWARE : SCALEPACK
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 57387
REMARK 200 RESOLUTION RANGE HIGH (A) : 1.950
REMARK 200 RESOLUTION RANGE LOW (A) : 50.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7
REMARK 200 DATA REDUNDANCY : NULL
REMARK 200 R MERGE (I) : NULL
REMARK 200 R SYM (I) : 0.10600
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 11.0400
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.95
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.05
REMARK 200 COMPLETENESS FOR SHELL (%) : 99.8
REMARK 200 DATA REDUNDANCY IN SHELL : NULL
REMARK 200 R MERGE FOR SHELL (I) : 0.41400
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.990
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: PHASER
REMARK 200 STARTING MODEL: PDB ENTRY 1M52
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 57.88
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.92
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M CITRIC ACID PH 3.5, 25% PEG 3350,
REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,-Y,Z
REMARK 290 3555 -X+1/2,Y+1/2,-Z
REMARK 290 4555 X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 52.19300
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 65.74350
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 52.19300
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 65.74350
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1, 2
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350
REMARK 350 BIOMOLECULE: 2
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: B
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 GLY A 245
REMARK 465 HIS A 246
REMARK 465 MET A 247
REMARK 465 SER A 248
REMARK 465 PRO A 249
REMARK 465 ASN A 250
REMARK 465 TYR A 251
REMARK 465 GLU A 524
REMARK 465 VAL A 525
REMARK 465 GLU A 526
REMARK 465 LYS A 527
REMARK 465 GLU A 528
REMARK 465 LEU A 529
REMARK 465 GLY A 530
REMARK 465 LYS A 531
REMARK 465 GLY B 245
REMARK 465 HIS B 246
REMARK 465 MET B 247
REMARK 465 SER B 248
REMARK 465 PRO B 249
REMARK 465 ASN B 250
REMARK 465 TYR B 251
REMARK 465 GLU B 524
REMARK 465 VAL B 525
REMARK 465 GLU B 526
REMARK 465 LYS B 527
REMARK 465 GLU B 528
REMARK 465 LEU B 529
REMARK 465 GLY B 530
REMARK 465 LYS B 531
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: CLOSE CONTACTS
REMARK 500
REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC
REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15
REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A
REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375
REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE
REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS.
REMARK 500
REMARK 500 DISTANCE CUTOFF:
REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS
REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS
REMARK 500
REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE
REMARK 500 O HOH A 717 O HOH A 717 2455 2.03
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 THR A 296 -107.68 -105.29
REMARK 500 ASP A 382 71.30 -153.04
REMARK 500 PRO A 421 92.86 -67.24
REMARK 500 TYR A 459 58.21 39.80
REMARK 500 ASP A 474 30.63 71.09
REMARK 500 LYS B 264 -82.24 -108.63
REMARK 500 LYS B 281 -62.48 -16.99
REMARK 500 LYS B 282 -74.90 -33.91
REMARK 500 SER B 284 26.83 48.73
REMARK 500 LYS B 293 171.75 -55.53
REMARK 500 PRO B 328 -134.89 -50.28
REMARK 500 PRO B 329 57.30 15.67
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE P16 A 532
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE P16 B 532
DBREF 2G2H A 248 531 UNP P00519 ABL1_HUMAN 229 512
DBREF 2G2H B 248 531 UNP P00519 ABL1_HUMAN 229 512
SEQADV 2G2H GLY A 245 UNP P00519 CLONING ARTIFACT
SEQADV 2G2H HIS A 246 UNP P00519 CLONING ARTIFACT
SEQADV 2G2H MET A 247 UNP P00519 CLONING ARTIFACT
SEQADV 2G2H PRO A 415 UNP P00519 HIS 396 ENGINEERED MUTATION
SEQADV 2G2H GLY B 245 UNP P00519 CLONING ARTIFACT
SEQADV 2G2H HIS B 246 UNP P00519 CLONING ARTIFACT
SEQADV 2G2H MET B 247 UNP P00519 CLONING ARTIFACT
SEQADV 2G2H PRO B 415 UNP P00519 HIS 396 ENGINEERED MUTATION
SEQRES 1 A 287 GLY HIS MET SER PRO ASN TYR ASP LYS TRP GLU MET GLU
SEQRES 2 A 287 ARG THR ASP ILE THR MET LYS HIS LYS LEU GLY GLY GLY
SEQRES 3 A 287 GLN TYR GLY GLU VAL TYR GLU GLY VAL TRP LYS LYS TYR
SEQRES 4 A 287 SER LEU THR VAL ALA VAL LYS THR LEU LYS GLU ASP THR
SEQRES 5 A 287 MET GLU VAL GLU GLU PHE LEU LYS GLU ALA ALA VAL MET
SEQRES 6 A 287 LYS GLU ILE LYS HIS PRO ASN LEU VAL GLN LEU LEU GLY
SEQRES 7 A 287 VAL CYS THR ARG GLU PRO PRO PHE TYR ILE ILE THR GLU
SEQRES 8 A 287 PHE MET THR TYR GLY ASN LEU LEU ASP TYR LEU ARG GLU
SEQRES 9 A 287 CYS ASN ARG GLN GLU VAL ASN ALA VAL VAL LEU LEU TYR
SEQRES 10 A 287 MET ALA THR GLN ILE SER SER ALA MET GLU TYR LEU GLU
SEQRES 11 A 287 LYS LYS ASN PHE ILE HIS ARG ASP LEU ALA ALA ARG ASN
SEQRES 12 A 287 CYS LEU VAL GLY GLU ASN HIS LEU VAL LYS VAL ALA ASP
SEQRES 13 A 287 PHE GLY LEU SER ARG LEU MET THR GLY ASP THR TYR THR
SEQRES 14 A 287 ALA PRO ALA GLY ALA LYS PHE PRO ILE LYS TRP THR ALA
SEQRES 15 A 287 PRO GLU SER LEU ALA TYR ASN LYS PHE SER ILE LYS SER
SEQRES 16 A 287 ASP VAL TRP ALA PHE GLY VAL LEU LEU TRP GLU ILE ALA
SEQRES 17 A 287 THR TYR GLY MET SER PRO TYR PRO GLY ILE ASP LEU SER
SEQRES 18 A 287 GLN VAL TYR GLU LEU LEU GLU LYS ASP TYR ARG MET GLU
SEQRES 19 A 287 ARG PRO GLU GLY CYS PRO GLU LYS VAL TYR GLU LEU MET
SEQRES 20 A 287 ARG ALA CYS TRP GLN TRP ASN PRO SER ASP ARG PRO SER
SEQRES 21 A 287 PHE ALA GLU ILE HIS GLN ALA PHE GLU THR MET PHE GLN
SEQRES 22 A 287 GLU SER SER ILE SER ASP GLU VAL GLU LYS GLU LEU GLY
SEQRES 23 A 287 LYS
SEQRES 1 B 287 GLY HIS MET SER PRO ASN TYR ASP LYS TRP GLU MET GLU
SEQRES 2 B 287 ARG THR ASP ILE THR MET LYS HIS LYS LEU GLY GLY GLY
SEQRES 3 B 287 GLN TYR GLY GLU VAL TYR GLU GLY VAL TRP LYS LYS TYR
SEQRES 4 B 287 SER LEU THR VAL ALA VAL LYS THR LEU LYS GLU ASP THR
SEQRES 5 B 287 MET GLU VAL GLU GLU PHE LEU LYS GLU ALA ALA VAL MET
SEQRES 6 B 287 LYS GLU ILE LYS HIS PRO ASN LEU VAL GLN LEU LEU GLY
SEQRES 7 B 287 VAL CYS THR ARG GLU PRO PRO PHE TYR ILE ILE THR GLU
SEQRES 8 B 287 PHE MET THR TYR GLY ASN LEU LEU ASP TYR LEU ARG GLU
SEQRES 9 B 287 CYS ASN ARG GLN GLU VAL ASN ALA VAL VAL LEU LEU TYR
SEQRES 10 B 287 MET ALA THR GLN ILE SER SER ALA MET GLU TYR LEU GLU
SEQRES 11 B 287 LYS LYS ASN PHE ILE HIS ARG ASP LEU ALA ALA ARG ASN
SEQRES 12 B 287 CYS LEU VAL GLY GLU ASN HIS LEU VAL LYS VAL ALA ASP
SEQRES 13 B 287 PHE GLY LEU SER ARG LEU MET THR GLY ASP THR TYR THR
SEQRES 14 B 287 ALA PRO ALA GLY ALA LYS PHE PRO ILE LYS TRP THR ALA
SEQRES 15 B 287 PRO GLU SER LEU ALA TYR ASN LYS PHE SER ILE LYS SER
SEQRES 16 B 287 ASP VAL TRP ALA PHE GLY VAL LEU LEU TRP GLU ILE ALA
SEQRES 17 B 287 THR TYR GLY MET SER PRO TYR PRO GLY ILE ASP LEU SER
SEQRES 18 B 287 GLN VAL TYR GLU LEU LEU GLU LYS ASP TYR ARG MET GLU
SEQRES 19 B 287 ARG PRO GLU GLY CYS PRO GLU LYS VAL TYR GLU LEU MET
SEQRES 20 B 287 ARG ALA CYS TRP GLN TRP ASN PRO SER ASP ARG PRO SER
SEQRES 21 B 287 PHE ALA GLU ILE HIS GLN ALA PHE GLU THR MET PHE GLN
SEQRES 22 B 287 GLU SER SER ILE SER ASP GLU VAL GLU LYS GLU LEU GLY
SEQRES 23 B 287 LYS
HET P16 A 532 29
HET P16 B 532 29
HETNAM P16 6-(2,6-DICHLOROPHENYL)-2-{[3-(HYDROXYMETHYL)
HETNAM 2 P16 PHENYL]AMINO}-8-METHYLPYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE
HETSYN P16 PD166326
FORMUL 3 P16 2(C21 H16 CL2 N4 O2)
FORMUL 5 HOH *413(H2 O)
HELIX 1 1 GLU A 257 THR A 259 5 3
HELIX 2 2 GLY A 268 GLN A 271 5 4
HELIX 3 3 LYS A 282 SER A 284 5 3
HELIX 4 4 GLU A 298 LYS A 310 1 13
HELIX 5 5 ASN A 341 CYS A 349 1 9
HELIX 6 6 ASN A 355 LYS A 376 1 22
HELIX 7 7 ALA A 384 ARG A 386 5 3
HELIX 8 8 GLU A 392 HIS A 394 5 3
HELIX 9 9 PRO A 421 THR A 425 5 5
HELIX 10 10 ALA A 426 ASN A 433 1 8
HELIX 11 11 SER A 436 THR A 453 1 18
HELIX 12 12 ASP A 463 SER A 465 5 3
HELIX 13 13 GLN A 466 LYS A 473 1 8
HELIX 14 14 PRO A 484 TRP A 495 1 12
HELIX 15 15 ASN A 498 ARG A 502 5 5
HELIX 16 16 SER A 504 ILE A 521 1 18
HELIX 17 17 GLU B 257 THR B 259 5 3
HELIX 18 18 GLY B 268 GLN B 271 5 4
HELIX 19 19 GLU B 298 ILE B 312 1 15
HELIX 20 20 ASN B 341 CYS B 349 1 9
HELIX 21 21 ASN B 355 LYS B 376 1 22
HELIX 22 22 ALA B 384 ARG B 386 5 3
HELIX 23 23 GLU B 392 HIS B 394 5 3
HELIX 24 24 PRO B 421 THR B 425 5 5
HELIX 25 25 ALA B 426 ASN B 433 1 8
HELIX 26 26 SER B 436 THR B 453 1 18
HELIX 27 27 ASP B 463 SER B 465 5 3
HELIX 28 28 GLN B 466 LYS B 473 1 8
HELIX 29 29 PRO B 484 TRP B 495 1 12
HELIX 30 30 ASN B 498 ARG B 502 5 5
HELIX 31 31 SER B 504 SER B 519 1 16
SHEET 1 A 5 ILE A 261 LYS A 266 0
SHEET 2 A 5 GLU A 274 TRP A 280 -1 O GLU A 277 N HIS A 265
SHEET 3 A 5 LEU A 285 THR A 291 -1 O VAL A 287 N GLY A 278
SHEET 4 A 5 TYR A 331 GLU A 335 -1 O ILE A 332 N LYS A 290
SHEET 5 A 5 LEU A 320 CYS A 324 -1 N LEU A 321 O ILE A 333
SHEET 1 B 2 PHE A 378 HIS A 380 0
SHEET 2 B 2 LEU A 403 ARG A 405 -1 O SER A 404 N ILE A 379
SHEET 1 C 2 CYS A 388 GLY A 391 0
SHEET 2 C 2 LEU A 395 VAL A 398 -1 O LYS A 397 N LEU A 389
SHEET 1 D 2 TYR A 412 THR A 413 0
SHEET 2 D 2 LYS A 434 PHE A 435 -1 O PHE A 435 N TYR A 412
SHEET 1 E 5 ILE B 261 LYS B 266 0
SHEET 2 E 5 VAL B 275 TRP B 280 -1 O GLU B 277 N HIS B 265
SHEET 3 E 5 LEU B 285 LEU B 292 -1 O VAL B 287 N GLY B 278
SHEET 4 E 5 PHE B 330 GLU B 335 -1 O ILE B 332 N LYS B 290
SHEET 5 E 5 LEU B 320 CYS B 324 -1 N LEU B 321 O ILE B 333
SHEET 1 F 2 PHE B 378 HIS B 380 0
SHEET 2 F 2 LEU B 403 ARG B 405 -1 O SER B 404 N ILE B 379
SHEET 1 G 2 CYS B 388 VAL B 390 0
SHEET 2 G 2 VAL B 396 VAL B 398 -1 O LYS B 397 N LEU B 389
SHEET 1 H 2 TYR B 412 THR B 413 0
SHEET 2 H 2 LYS B 434 PHE B 435 -1 O PHE B 435 N TYR B 412
CISPEP 1 PRO A 328 PRO A 329 0 -0.34
SITE 1 AC1 17 TYR A 272 ALA A 288 VAL A 289 LYS A 290
SITE 2 AC1 17 MET A 309 ILE A 332 THR A 334 GLU A 335
SITE 3 AC1 17 PHE A 336 MET A 337 THR A 338 GLY A 340
SITE 4 AC1 17 LEU A 389 ALA A 399 ASP A 400 PHE A 401
SITE 5 AC1 17 HOH A 646
SITE 1 AC2 16 TYR B 272 ALA B 288 LYS B 290 GLU B 305
SITE 2 AC2 16 MET B 309 ILE B 332 THR B 334 GLU B 335
SITE 3 AC2 16 PHE B 336 MET B 337 GLY B 340 LEU B 389
SITE 4 AC2 16 ALA B 399 ASP B 400 PHE B 401 HOH B 664
CRYST1 104.386 131.487 56.499 90.00 90.00 90.00 P 21 21 2 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.009580 0.000000 0.000000 0.00000
SCALE2 0.000000 0.007605 0.000000 0.00000
SCALE3 0.000000 0.000000 0.017699 0.00000